Lenvatinib inhibits angiogenesis and tumor fibroblast growth factor signaling pathways in human hepatocellular carcinoma models
Abstract Unresectable hepatocellular carcinoma (uHCC) is one of the most lethal and prevalent cancers worldwide, and current systemic therapeutic options for uHCC are limited. Lenvatinib, a multiple receptor tyrosine kinase inhibitor targeting vascular endothelial growth factor receptors (VEGFRs) an...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Sprog: | engelsk |
| Udgivet: |
Wiley
2018-06-01
|
| Serier: | Cancer Medicine |
| Fag: | |
| Online adgang: | https://doi.org/10.1002/cam4.1517 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|